Autosomal Dominant Optic Atrophy
Oncology
Prevalence
75.0 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| stk-002 | Stoke Therapeutics, Inc. (STOK) |
Preclinical(1)
| Drug | Company |
|---|---|
| ABO-505 | ABEONA THERAPEUTICS INC. (ABEO) |
Compare drugs
Frequently asked questions
How many drugs are in development for Autosomal Dominant Optic Atrophy?
BioSniper tracks 2 drugs in development for Autosomal Dominant Optic Atrophy across 2 companies.
How many clinical trials target Autosomal Dominant Optic Atrophy?
There are 1 clinical trial targeting Autosomal Dominant Optic Atrophy tracked by BioSniper.
What is the prevalence of Autosomal Dominant Optic Atrophy?
The estimated prevalence of Autosomal Dominant Optic Atrophy is approximately 75.0 per 100,000 population.
Deep-dive into Autosomal Dominant Optic Atrophy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis